M. E. Masterson
Memorial Sloan Kettering Cancer Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M. E. Masterson.
International Journal of Radiation Oncology Biology Physics | 1991
M. E. Masterson; Glenn D. Barest; Chen Shou Chui; Karen P. Doppke; Robert Epperson; William B. Harms; Kenneth Krippner; Radhe Mohan; Eric D. Slessinger; Marc R. Sontag; Marcia Urie; Robert Wallace; John W. Wong
Under the auspices of NCI contracts, four institutions have collaborated to assess the accuracy of the pixel-based dose calculation methods they employ for external photon treatment planning. The approach relied on comparing calculations using each groups algorithm with measurements in phantoms of increasing complexity. The first set of measurements consisted of ionization chamber measurements in water phantoms in normally incident square fields, an elongated field, a wedged field, a blocked field, and an obliquely incident beam. The second group of measurements was carried out using thermoluminescent dosimeters in phantoms designed to investigate the effects of surface curvature, high density heterogeneities, and low density heterogeneities. The final study tested the entire treatment planning system, including CT data conversion, in an anthropomorphic phantom. Overall, good agreement between calculation and measurements was found for all algorithms. Regions in which discrepancies were observed are pointed out, areas for algorithm improvement are identified and the clinical import of algorithm accuracy is discussed.
International Journal of Radiation Oncology Biology Physics | 1994
G Mageras; Zvi Fuks; James P. O'Brien; Linda J. Brewster; C Burman; Chen-Shou Chui; Steven A. Leibel; C.C. Ling; M. E. Masterson; Radhe Mohan; G.J. Kutcher
PURPOSE We have described previously a model for delivering computer-controlled radiation treatments. We report here on the implementation and first years clinical experience with such treatments using a 50 MeV medical microtron. METHODS AND MATERIALS The microtron is equipped with a multileaf collimator and is capable of setting up and treating a sequence of fixed fields called segments, under computer control. An external computer derives machine parameters for the segments from a three-dimensional treatment planning system, transfers them to the microtron control computer, checks the machine settings before allowing dose delivery to begin, and records the treatment. We describe the patient treatment methodology, portal film acquisition, electronic portal imaging, and quality assurance. RESULTS Patient treatments began in July 1992, comprising six-segment conformal treatments of the prostate. Using the recorded treatment data, the system performance has been examined and compared to other treatment machines. The average treatment time is 10 min, of which 4 min is for computer-controlled setup and irradiation; the remaining time is for patient positioning and checking of clearances. Long-term reproducibility of computer-controlled setup of the gantry and multileaf position is better than 0.5 degrees and 1 mm, respectively. Termination due to a machine fault has occurred in 5.5% of treatments, improving to 2.5% in recent months. CONCLUSION Our initial experience indicates that computer-controlled segmental therapy can be performed reliably on a routine basis. Treatment times with the microtron are significantly shorter than with conventional linacs, and setup accuracy is consistent with that needed for conformal therapy. We believe that treatment times can be further improved through software upgrades and integration of electronic portal imaging.
Medical Physics | 1992
M. E. Masterson; Robert Febo
The irradiation of blood before transfusion into immunosuppressed patients is an increasingly common technique used to prevent graft-versus-host disease. A technical procedure is described for the calibration of blood irradiators, including the determination of absolute dose rate and relative dose distribution over the blood volume. Results of dose rate measurements on commercially available irradiators indicate differences of +5% to -13% with manufacturer-supplied calibrations and variations in the relative dose rate over the irradiation volume from 70% to 180%. The clinical implications of these findings and the need for accurate dosimetry are discussed.
Medical Physics | 1989
M. E. Masterson; R. McGary; K. Schmitt; Jason A. Koutcher
A methodology for evaluating the accuracy and reproducibility of calculated T1s and T2s has been developed and applied to a General Electric 1.5 T Signa System. Specifically studied were absolute accuracy and temporal stability of image derived T1s and T2s as well as the dependence of calculated relaxation times on position in the scan plane, position along the axis of the magnet bore, the scan plane orientation (axial, sagittal, coronal), and the center frequency. The results of this study of the accuracy and reproducibility of image relaxation times have direct bearing on the design of clinical investigations assessing the diagnostic usefulness of these values.
Medical Physics | 1995
M. E. Masterson; C Chui; Robert Febo; J. D. Hung; Zvi Fuks; Radhe Mohan; C.C. Ling; G.J. Kutcher; S. Bjork; J. Enstrom
The first of a new generation of microtron accelerators has been installed and tested. It is currently in use for multisegment conformal radiotherapy at our institution. The unit produces x rays and electrons from 10 to 50 MeV in 5 MeV increments. It incorporates a 64 leaf, doubly focused multileaf collimator (MLC), which can be used to shape x-ray and electron beams. Both x-ray and electron beams are produced by magnetically scanning the electron beams from the accelerator. The new generation unit incorporates a purging magnet to sweep away any primary or secondary electrons that pass through the target(s). In this paper, the beam characteristics of the accelerator that were studied during acceptance testing are described. Representative examples of depth doses, beam profiles, output factors, and elementary beam distributions are presented and discussed, in comparison with the earlier generation of microtron accelerators and with other radiotherapy machines.
Nuclear Medicine and Biology | 1995
Omer Ugur; Andrew M. Scott; Lale Kostakoglu; T. Edmond Hui; M. E. Masterson; Robert Febo; George Sgouros; Eddie Rosa; Bipin M. Mehta; Darrell R. Fisher; Nai Kong V Cheung; Steven M. Larson
Preclinical evaluation of the therapeutic potential of radiolabeled antibodies is commonly performed in a xenografted nude mouse model. To assess therapeutic efficacy it is important to estimate the absorbed dose to the tumor and normal tissues of the nude mouse. The current study was designed to accurately measure radiation does to human neuroblastoma xenografts and normal organs in nude mice treated with I-131-labeled 3F8 monoclonal antibody (MoAb) against disialoganglioside GD2 antigen. Absorbed dose estimates were obtained using two different approaches: (1) measurement with teflon-imbedded CaSO4:Dy mini-thermoluminescent dosimeters (TLDs) and (2) calculations using mouse S-factors. The calculated total dose to tumor one week after i.v. injection of the 50 microCi I-131-3F8 MoAb was 604 cGy. The corresponding decay corrected and not corrected TLD measurements were 109 +/- 9 and 48.7 +/- 3.4 cGy respectively. The calculated to TLD-derived dose ratios for tumor ranged from 6.1 at 24 h to 5.5 at 1 week. The light output fading rate was found to depend upon the tissue type within which the TLDs were implanted. The decay rate in tumor, muscle, subcutaneous tissue and in vitro, were 9.5, 5.0, 3.7 and 0.67% per day, respectively. We have demonstrated that the type of tissue in which the TLD was implanted strongly influenced the in vivo decay of light output. Even with decay correction, a significant discrepancy was observed between MIRD-based calculated and CaSO4:Dy mini-TLD measured absorbed doses. Batch dependence, pH of the tumor or other variables associated with TLDs which are not as yet well known may account for this discrepancy.
Application of Optical Instrumentation in Medicine XI | 1983
S. Malik; M. E. Masterson; Margie Hunt
Radiographs of a phantom containing excised breast tissue and idealized test objects embedded in tissue equivalent plastic have been obtained using a variety of mammographic film-screen detectors. A CGR Senographe (molybdenum target, beryllium window) was modified to accept a series of x-ray filters: 0.03 mm molybdenum, 0.5 mm aluminum or 1.2 mm aluminum. Radiographs were obtained at kVps ranging from 26 to 32 kVp with the mAs adjusted to achieve the same optical density on the films. Entrance skin exposure was measured for the range of techniques from which dependence of mean gland dose on kVp was derived. Indices of image quality were also determined from the radiographs. A discussion of the effects of kVp variation on mammographic image quality, especially on low contrast discrimination is included.
Seminars in Radiation Oncology | 1992
Steven A. Leibel; Gerald J. Kutcher; Radhe Mohan; Louis B. Harrison; John G. Armstrong; Michael J. Zelefsky; Thomas LoSasso; C Burman; G Mageras; Chen Shou Chui; Linda J. Brewster; M. E. Masterson; Yeh Chi Lo; C. Clifton Ling; Zvi Fuks
International Journal of Radiation Oncology Biology Physics | 1992
M. E. Masterson; G Mageras; T LoSasso; E. Joreskog; L.G. Larsson; B. Tsirakis; R. Febo; Radhe Mohan; C.C. Ling; Steven A. Leibel; Zvi Fuks; G.J. Kutcher
International Journal of Radiation Oncology Biology Physics | 1992
Yeh Chi Lo; G.J. Kutcher; M. E. Masterson; Steven A. Leibel; Zvi Fuks